Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Germ Cell and Embryonal

Explore clinical trials studying Neoplasms, Germ Cell and Embryonal. Study availability and eligibility vary by location and protocol.

6,098 public trials 1,231 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Germ Cell and Embryonal trial results

Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

NCT04919226

Conditions
Gastro-enteropancreatic neuroendocrine tumor, Neoplasms, Neoplasms by Histologic Type, +4 more
Locations
  • Stanford Cancer Center Palo Alto, California, United States
  • University of Colorado Hospital, Nuclear Medicine Aurora, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma

NCT03470922

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Local Institution - 0010 Tucson, Arizona, United States
  • Local Institution - 0020 Los Angeles, California, United States
  • Coastal Integrative Cancer Care San Luis Obispo, California, United States
  • Local Institution - 0116 Santa Barbara, California, United States
View all 127 locations
View Trial Details
Active, Not Recruiting

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

NCT00978458

Conditions
Astrocytoma, Brain Diseases, Brain Neoplasms, +19 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • Arizona Oncology Services Foundation Phoenix, Arizona, United States
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center Orange, California, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs

NCT05459844

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +3 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The First Afilliated Hospital of Fujian Medical University Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
  • The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
View all 23 locations
View Trial Details
Active, Not Recruiting

GammaTile and Stupp in Newly Diagnosed GBM

NCT05342883

Conditions
Astrocytoma, Glioblastoma, Glioma, +7 more
Locations
  • HonorHeath Scottsdale Osborn Medical Center Scottsdale, Arizona, United States
  • Keck Medicine of USC Los Angeles, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Advent Health Orlando Orlando, Florida, United States
View all 16 locations
View Trial Details
Active, Not Recruiting

Assessment of PK Similarity of FYB206 in Comparison With Keytruda in Resected Stage II or III Melanoma Patients

NCT06551064

Conditions
Melanoma, Melanoma Stage III, Melanoma, Stage II, +11 more
Locations
  • Formycon Investigative Site Sarajevo, Bosnia and Herzegovina
  • Formycon Investigative Site Sofia, Bulgaria
  • Formycon Investigative Site Tartu, Estonia
  • Formycon Investigative Site Batumi, Georgia
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study of FF-10850 Topotecan Liposome Injection in Advanced Solid Tumors Including Merkel Cell Carcinoma

NCT04047251

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +15 more
Locations
  • HonorHealth Scottsdale, Arizona, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Dana Farber Cancer Institute (DFCI) Boston, Massachusetts, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details

Related conditions